BIO peer analysis
Bio-Rad (BIO) against its competitors: price, today's move, 1-year return and market value side by side.
BIO and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| AZTA Azenta | $35.52 | -9.06% | 18.80% | – |
| BRKR Bruker | $55.67 | -2.44% | 52.95% | $8.70B |
| DHR Danaher | $228.11 | -1.77% | 6.07% | $163.25B |
| LAB Standard BioTools | $0.61 | -1.61% | -46.96% | – |
| MRVI Maravai LifeSciences | $7.15 | -8.45% | 127.71% | – |
| PACB Pacific Biosciences | $2.34 | -9.98% | 20.88% | $809.71M |
| RGEN Repligen | $172.95 | -2.26% | 19.63% | $11.23B |
| RVTY Revvity | $151.70 | -3.38% | 66.67% | – |
| TECH Bio-Techne | $72.68 | 0.03% | 19.23% | $11.41B |
| TMO Thermo Fisher | $682.81 | -2.04% | 22.76% | $257.71B |
| BIO Bio-Rad | $366.21 | -1.60% | 20.22% | $9.95B |
- BIO's peers: AZTA (Azenta), BRKR (Bruker), DHR (Danaher), LAB (Standard BioTools), MRVI (Maravai LifeSciences), PACB (Pacific Biosciences), RGEN (Repligen), RVTY (Revvity).
Updated 2026-11-03 02:48 UTC